MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Geschlossen

3.32 -14.21

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.23

Max

3.71

Schlüsselkennzahlen
By Trading Economics
Einkommen	1.3M -3M
Verkäufe	100K 100K
Gewinnspanne	-2,954
Angestellte	21

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-578K 39M
Vorheriger Eröffnungskurs	17.53
Vorheriger Schlusskurs	3.32

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

15. Apr. 2026, 23:14 UTC

Ergebnisse

Battery Maker CATL First-Quarter Net Rose on Strong Demand

15. Apr. 2026, 23:14 UTC

Ergebnisse

Battery Maker CATL First Quarter Net Rose On Strong Demand

15. Apr. 2026, 17:13 UTC

Wichtige Markttreiber

Tesla Shares Rise on Completion of AI5 Chip Design Process

15. Apr. 2026, 23:39 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

15. Apr. 2026, 23:35 UTC

Market Talk

Wichtige Nachrichtenereignisse

Gold Rises Amid Hopes for More U.S.-Iran Talks -- Market Talk

15. Apr. 2026, 22:41 UTC

Ergebnisse

CATL 1Q Net CNY20.74 Vs. Net CNY13.96B >300750.SZ

15. Apr. 2026, 22:38 UTC

Ergebnisse

CATL 1Q Rev CNY129.13B Vs. CNY84.70B >300750.SZ

15. Apr. 2026, 22:15 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. Apr. 2026, 22:15 UTC

Market Talk

J.B. Hunt Flag Fundamental Shift in 1Q -- Market Talk

15. Apr. 2026, 22:14 UTC

Ergebnisse

Lens Technology Results Weighed by Lower Rev From Smartphone, Computer Business >300433.SZ

15. Apr. 2026, 22:12 UTC

Ergebnisse

Lens Technology 1Q Oper Income CNY14.14B Vs. CNY17.06B>300433.SZ

15. Apr. 2026, 22:11 UTC

Ergebnisse

Lens Technology 1Q Loss CNY149.60M Vs. Net CNY428.88M >300433.SZ

15. Apr. 2026, 22:11 UTC

Ergebnisse

Lens Technology Swings to Loss in 1Q>300433.SZ

15. Apr. 2026, 22:07 UTC

Ergebnisse

Big Bank Earnings Show Consumers Are on Solid Ground -- Against All Odds -- Barrons.com

15. Apr. 2026, 21:34 UTC

Akquisitionen, Fusionen, Übernahmen

Skild AI Acquires Zebra Technologies' Robotics Automation Business

15. Apr. 2026, 21:29 UTC

Heiße Aktien

Stocks to Watch: Bank of America, Live Nation, Snap, Hermès -- WSJ

15. Apr. 2026, 20:50 UTC

Market Talk

Ergebnisse

Financial Services Roundup: Market Talk

15. Apr. 2026, 20:30 UTC

Ergebnisse

PepsiCo Cuts Prices, Revamps Products. Earnings Will Show if It's Working. -- Barrons.com

15. Apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15. Apr. 2026, 20:06 UTC

Market Talk

Silver Inches Up as Attention Turns to World Deficit -- Market Talk

15. Apr. 2026, 19:46 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Jamie Dimon Says JPMorgan Stock Isn't Cheap. Why the Bank Is Still Buying Back Billions. -- Barrons.com

15. Apr. 2026, 19:25 UTC

Market Talk

Automakers' 1Q Earnings Could Give Clues to EV Comeback -- Market Talk

15. Apr. 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Edges Up Ahead of Storage Data -- Market Talk

15. Apr. 2026, 18:58 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Settles Flat As Market Awaits Conflict Developments -- Market Talk

15. Apr. 2026, 18:11 UTC

Akquisitionen, Fusionen, Übernahmen

Three Lessons From Amazon's Blockbuster Deal to Buy Globalstar -- Barrons.com

15. Apr. 2026, 17:45 UTC

Akquisitionen, Fusionen, Übernahmen

Apple CEO Tim Cook Buys Nike Stock. His Last Purchase Didn't Go So Well. -- Barrons.com

15. Apr. 2026, 16:58 UTC

Ergebnisse

Bank of America's Wealth Management Profits Rise Amid 'Resilient' U.S. Economy -- Barrons.com

15. Apr. 2026, 16:52 UTC

Ergebnisse

Snap and Other Companies Blame AI for Layoffs. Is It Just a Convenient Excuse? -- Barrons.com

15. Apr. 2026, 16:46 UTC

Market Talk

Wichtige Nachrichtenereignisse

U.S. Crude Oil Stocks Finally See Drawdowns -- Market Talk

15. Apr. 2026, 16:37 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.